Many of the new cost-containment strategies now underway in original Medicare were pioneered in Medicare Advantage.
Let’s give our family caregivers and their patients the healthcare relief they need and deserve.
America’s proud scientific legacy in the biomedical sciences is in danger.
A new proposal from the Food and Drug Administration would undermine generic availability, and put both patient safety and healthcare savings at risk.
“First, do no harm,” is a core tenant of the Hippocratic Oath taken by medical students who enter the healing profession.
Unfortunately, proposals being considered in Congress would violate that essential ethical principle.
In the valid effort to control the enormous cost of healthcare, could we be jeopardizing the very healthcare funded innovations that previously contributed to our nation’s well-being?
Unfortunately, saying you want to fix Obamacare appears to be easier than actually fixing it.
Recent reports indicate that drug shortages persist in being a significant public health threat.
Decades have come and gone, healthcare and science have become more effective and sophisticated, yet outcomes for black women have hardly budged.
The draft tax reform proposal would eliminate incentives for drug manufacturers to develop therapies to treat and cure the more than 7,000 rare diseases afflicting more than 30 million Americans.